← Back to Search

Comprehensive Pre-ESKD Education for Chronic Kidney Disease (TEACH-VET Trial)

N/A

Recruiting

Led By Ashutosh M. Shukla, MD MBBS

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Advanced CKD (stage 4 or 5) and not on dialysis

18 years or older

Must not have

Veterans with diagnosed dementia

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3-48 months

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing whether a comprehensive education program can improve care for Veterans with chronic kidney disease.

Who is the study for?

This trial is for Veterans aged 18 or older with advanced chronic kidney disease (stage 4 or 5) who are not on dialysis and receive healthcare from the NF/SG VHS. It excludes non-English speakers, those with dementia, homeless veterans, those in assisted living or nursing homes, and individuals expected to live less than six months.

What is being tested?

The study tests whether comprehensive pre-end stage renal disease education can improve knowledge of CKD among Veterans and lead to more choosing home dialysis—a better but underused treatment. The impact on patient confidence and health service outcomes will also be evaluated.

What are the potential side effects?

Since this trial involves educational interventions rather than medications, there are no direct medical side effects. However, participants may experience stress or anxiety when learning about their condition.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My kidney disease is advanced but I'm not on dialysis.

Select...

I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am a veteran diagnosed with dementia.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3-48 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3-48 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-48 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Home Dialysis Use

Secondary study objectives

Home Dialysis selection

Kidney Disease Knowledge

Satisfaction on Dialysis

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Active Control

Group I: Comprehensive Pre-ESRD Patient Education (CPE)Active Control1 Intervention

These patients will receive CPE for a total of up to 3 session in an intent-to-teach format, either via Face-to-face or telemedicine delivery.

Group II: Enhanced Usual CareActive Control1 Intervention

This group will receive usual care. This care will be enhanced by providing them with the freely available education material for the Kidney Disease Education

0 / 3Eligibility criteria met